RT Journal Article
T1 Antibiotic use in the COVID-19 crisis in Spain
A1 González Zorn, Bruno
AB Before the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance was the world`s most pressing health crisis. The United Nations, the World Health Organization (WHO) and the European Center for Disease Control and Prevention have made antimicrobial resistance a top priority, establishing a task force in the G-20 and organizing a joint program initiative on antimicrobial resistance including countries from al over the world [1]. However, with the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus pandemic in January 2020, all efforts are now focused on COVID-19, including controlling infections and developing vaccines
PB Elsevier
SN 1198-743X
YR 2021
FD 2021
LK https://hdl.handle.net/20.500.14352/130350
UL https://hdl.handle.net/20.500.14352/130350
LA eng
NO Gonzalez-Zorn B. (2021). Antibiotic use in the COVID-19 crisis in Spain. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(4), 646–647. https://doi.org/10.1016/j.cmi.2020.09.055
DS Docta Complutense
RD 22 abr 2026